Okumu, Fredros
Moore, Sarah J.
Selvaraj, Prashanth
Yafin, Arnon Houri
Juma, Elijah O.
Shirima, GloriaSalome G.
Majambere, Silas
Hardy, Andy
Knols, Bart G. J.
Msugupakulya, Betwel J.
Finda, Marceline
Kahamba, Najat
Thomsen, Edward
Ahmed, Ayman
Zohdy, Sarah
Chaki, Prosper
DeChant, Peter
Fornace, Kimberly
Govella, Nicodem
Gowelo, Steven
Hakizimana, Emmanuel
Hamainza, Busiku
Ijumba, Jasper N.
Jany, William
Kafy, Hmooda Toto
Kaindoa, Emmanuel W.
Kariuki, Lenson
Kiware, Samson
Kweka, Eliningaya J.
Lobo, Neil F.
Marrenjo, Dulcisária
Matoke-Muhia, Damaris
Mbogo, Charles
McCann, Robert S.
Monroe, April
Ndenga, Bryson Alberto
Ngowo, Halfan S.
Ochomo, Eric
Opiyo, Mercy
Reithinger, Richard
Sikaala, Chadwick Haadezu
Tatarsky, Allison
Takudzwa, David
Trujillano, Fedra
Sherrard-Smith, Ellie
Article History
Received: 25 September 2024
Accepted: 4 December 2024
First Online: 7 February 2025
Declarations
:
: Sarah Jane Moore (SJM) conducts evaluation of vector control products including larvicides for a number of manufacturers via funding for contract research to her employer without personal payment or consultancy. Therefore, there is no conflict of interest. Arnon Houri Yafin (AHY) is the CEO of ZzappMalaria, a company that develops software to support larval source management (LSM) operations. Silas Majambere (SM) works for Valent BioSciences LLC, a manufacturer of biological larvicides. William Jany (WJ) works for Clarke International, USA, a global provider of vector control devices. No other authors have conflicts of interest to declare.
: Not applicable.